SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001070081-20-000139
Filing Date
2020-10-29
Accepted
2020-10-29 16:37:54
Documents
90
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ptct-20200930x10q.htm   iXBRL 10-Q 2667547
2 EX-10.1 ptct-20200930ex101c45b08.htm EX-10.1 22339
3 EX-10.2 ptct-20200930ex1029e7222.htm EX-10.2 17447
4 EX-31.1 ptct-20200930ex311067de2.htm EX-31.1 10924
5 EX-31.2 ptct-20200930ex3123c96a2.htm EX-31.2 10726
6 EX-32.1 ptct-20200930ex3212402d0.htm EX-32.1 5945
7 EX-32.2 ptct-20200930ex322c3d0ad.htm EX-32.2 6131
  Complete submission text file 0001070081-20-000139.txt   12774703

Data Files

Seq Description Document Type Size
8 EX-101.SCH ptct-20200930.xsd EX-101.SCH 77546
9 EX-101.CAL ptct-20200930_cal.xml EX-101.CAL 87199
10 EX-101.DEF ptct-20200930_def.xml EX-101.DEF 386664
11 EX-101.LAB ptct-20200930_lab.xml EX-101.LAB 763701
12 EX-101.PRE ptct-20200930_pre.xml EX-101.PRE 645379
13 EXTRACTED XBRL INSTANCE DOCUMENT ptct-20200930x10q_htm.xml XML 2665912
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

IRS No.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35969 | Film No.: 201273118
SIC: 2834 Pharmaceutical Preparations